Navigation Links
Discovery of therapeutic peptides affecting mitochondria
Date:11/9/2011

pletion of the U.S. Phase I study. The preliminary results from this clinical trial demonstrated that Bendavia appeared to be well tolerated at the doses evaluated, with no serious adverse events reported. A Phase II clinical trial has already begun in several countries.

In the "Top Ten"

Windhover, a company owned by Elsevier that plays a major role in the production of health industry analyses, chose Bendavia as one of the "Top 10" projects to watch for in 2011 in the development of therapies for cardiovascular and metabolic diseases.


'/>"/>
Contact: Julie Langelier
julie.langelier@ircm.qc.ca
514-987-5555
Institut de recherches cliniques de Montreal
Source:Eurekalert

Page: 1 2

Related biology news :

1. Chemical equator discovery will aid pollution mapping
2. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
3. Groundbreaking discovery may lead to stronger antibiotics
4. Discovery of natural compounds that could slow blood vessel growth
5. Nanoscopic screening process to speed drug discovery
6. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
7. New $11 million center to speed production of new compounds for drug discovery
8. Discovery of giant roaming deep sea protist provides new perspective on animal evolution
9. New discovery may enhance MRI scans, lead to portable MRI machines
10. Kidney function discovery sheds light on genetic complexity of disease
11. Discovery of new gene associated with diabetes risk suggests link with body clock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2015)... Passwords have proven futile for securing ... U.S. Office of Personnel Management breach. Biometric authentication ... but developers and end-users are concerned about how ... Biometrics-as-a-Service provider HYPR Corp. announced today the general ... party integration. A video overview ...
(Date:7/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the fourth quarter and ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-455-2260 ...
(Date:7/8/2015)... -- Summary Pancreatic cancer is the 12th most ... a mortality rate of 10.9 deaths per 100,000 people ... has highlighted a significant need for new and improved ... the current market. A highly active pancreatic cancer ... types and mechanisms of action, which provides a striking ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... consists of billions of nerve cells enabling to learn, ... touch, smell or fear, millions of neurons in our ... other by chemical and electrical impulses to compute incoming ... With 20,000 - 25,000 genes in our genome, most ...
... 25 years, stem cells have been defined based on what ... different specialized cell types. But as genetic techniques have become ... of stem cells, based on the genes they express. ... genes under the control of a gene called Oct4 considered ...
... Inc. (OTC Bulletin Board: NRGX) today announced the publication in ... positive results from the first ever gene therapy trial for ... into a patient’s own brain cells for any adult neurodegenerative ... in 12 patients with advanced Parkinson’s disease demonstrated both a ...
Cached Biology News:Turn-ons and turn-offs for neurons 2Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state 2Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 2Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 3Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 4
(Date:7/27/2015)... MILWAUKEE, Wis. (PRWEB) , ... July 27, 2015 ... ... product and facility identification solutions, today announced a new video: 3 Ways ... with OSHA’s Hazard Communication Standard and the Globally Harmonized System (GHS) by effectively ...
(Date:7/27/2015)... ... 27, 2015 , ... BlueInGreen® announced the addition of EnviroSales ... the world’s most efficient gas dissolution technology to all of Florida, excluding the ... industrial and municipal markets. With offices located in Sarasota, Sebring and Melbourne Beach, ...
(Date:7/27/2015)... Junto Health, a company that helps major ... new technology solutions, today announced the launch of a ... in health care policy consulting. Working together with SPG, ... innovation process while, at the same time, they are ... health care finance and the delivery of health care ...
(Date:7/26/2015)... , ... July 26, 2015 , ... ... its VALIDATE® ANEMIA calibration verification / linearity test kit. The VALIDATE® ANEMIA kit ... VALIDATE® ANEMIA kit is prepared using the CLSI recommended “equal delta” method for ...
Breaking Biology Technology:Brady Releases “3 Roads to GHS Labels” Video 2BlueInGreen Brings Water Treatment Technology to Florida 2Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2
... Connected , the one-of-a-kind program of ... love, comes to Fresno, California on Friday and Saturday, ... Day. Connected honors California,s ... stress. (Photo:   http://photos.prnewswire.com/prnh/20101015/LA82180 ) ...
... a new technique that allows them to make molecular ... as discotic liquid crystals (DLCs). The findings could ... generation electronic devices, such as light-harvesting cells and low-cost ... in developing countries. DLCs are disk-shaped molecules that ...
... 14 Sequenom, Inc. (Nasdaq: SQNM ... clinical advisory board focusing on retinal diseases and ... guidance to Sequenom and Sequenom Center for Molecular ... care molecular diagnostics. (Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO ...
Cached Biology Technology:Connected! at The Fresno Revue 2Connected! at The Fresno Revue 3Scientists perfect new nanowire technique 2Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 2Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 3Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 4Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 5
For the development of an immunoprecipitation assay to measure Chk1 kinase activity in cell lysates....
Non-Protein Peroxidase Stabilizer , 1 L...
... Gelzyme is an agarose-digesting enzyme ... cleaves simple carbohydrate bonds in agarose ... longer gel. The remaining carbohydrate molecules ... manipulation. DNA isolated with Gelzyme enzyme ...
RABBIT ANTI QUINOLINIC ACID...
Biology Products: